Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

Abstract

Hemostatic therapy with rFVIIa reduced growth of the hematoma but did not improve survival or functional outcome after intracerebral hemorrhage. (ClinicalTrials.gov number, NCT00127283 [ClinicalTrials.gov].).